» Articles » PMID: 8554975

Incidence of Primary Liver Cancer and Aetiological Aspects: a Study of a Defined Population from a Low-endemicity Area

Overview
Journal Br J Cancer
Specialty Oncology
Date 1996 Jan 1
PMID 8554975
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of primary liver cancer (PLC) varies throughout the world. It has been attributed to variations in incidence of the predominant histological type, hepatocellular carcinoma (HCC). The incidence of PLC types other than HCC such as cholangiocellular carcinoma (CCC) is far less known, especially in low-incidence areas. The aetiology of HCC and other PLC types is obscure, with the exception of the association between HCC and cirrhosis as well as chronic viral hepatitis. The present retrospective incidence and aetiology study concerns a well-defined population from a period with a high autopsy frequency. Preserved biopsy specimens were re-evaluated histopathologically and patient records were studied. Among 590 histologically verified cases of PLC, HCC constituted 90%, CCC 8% and a mixed form of these types 1%. At the end of the study period the annual age-standardised incidence rate of HCC was 3.6 cases per 100,000 inhabitants. Other PLC types were hepatoblastoma (n = 3), fibrolamellar carcinoma (n = 2), angiosarcoma (n = 1) and infantile haemangioendothelioma (n = 1), each constituting less than 1% of the PLC cases. Comparing HCC with CCC we found that cirrhosis (70%) and alcoholism (21%) was significantly more frequent in HCC, and cholelithiasis was significantly more common (60%) in patients with CCC. In the majority of the PLC cases with liver cirrhosis this disorder was unknown before diagnosis of the tumour.

Citing Articles

Risk of Cancer and Subsequent Mortality in Primary Biliary Cholangitis: A Population-based Cohort Study of 3052 Patients.

Schonau J, Wester A, Schattenberg J, Hagstrom H Gastro Hep Adv. 2024; 2(7):879-888.

PMID: 39130771 PMC: 11307889. DOI: 10.1016/j.gastha.2023.05.004.


Novel allele associations with susceptibility, staging, symptomatic state, autoimmune hepatitis and hepatocellular carcinoma events for primary biliary cholangitis in the Japanese population.

Khor S, Ueno K, Nishida N, Kawashima M, Kawai Y, Aiba Y Front Immunol. 2023; 14:1151502.

PMID: 37325616 PMC: 10264690. DOI: 10.3389/fimmu.2023.1151502.


Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.

Coppola N, Marrone A, Pisaturo M, Starace M, Signoriello G, Gentile I Eur J Clin Microbiol Infect Dis. 2013; 33(4):559-67.

PMID: 24081499 DOI: 10.1007/s10096-013-1985-7.


Increased porphyrins in primary liver cancer mainly reflect a parallel liver disease.

Kaczynski J, Hansson G, Wallerstedt S Gastroenterol Res Pract. 2009; 2009:402394.

PMID: 19841684 PMC: 2763134. DOI: 10.1155/2009/402394.


Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma.

Qiang L, Huikai L, Butt K, Wang P, Hao X World J Surg. 2006; 30(3):439-45.

PMID: 16479331 DOI: 10.1007/s00268-005-0608-6.

References
1.
Bouchier I . Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver. Gut. 1969; 10(9):705-10. PMC: 1552971. DOI: 10.1136/gut.10.9.705. View

2.
Bengmark S, Borjesson B, Hafstrom L . The natural history of primary carcinoma of the liver. Scand J Gastroenterol. 1971; 6(4):351-5. DOI: 10.3109/00365527109181132. View

3.
LANDER J, Stanley R, Sumner H, Boswell D, AACH R . Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite). Gastroenterology. 1975; 68(6):1582-6. View

4.
Popper H, THOMAS L, TELLES N, Falk H, SELIKOFF I . Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol. 1978; 92(2):349-76. PMC: 2018292. View

5.
Lefkowitch J . The epidemiology and morphology of primary malignant liver tumors. Surg Clin North Am. 1981; 61(1):169-80. DOI: 10.1016/s0039-6109(16)42341-8. View